Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunodeficiency, xanthomas and obstructive liver disease

J N Isenberg, R F Hanson, G C Williams

    The American Journal of Medicine
    |September 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same author

    Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same author

    Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
    Same author

    Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.

    Bone·2018
    Same author

    The use of the bacteriocin, nisin, as a preservative in pasteurized liquid whole egg.

    Letters in applied microbiology·2018
    Same author

    Physical activity and motivational predictors of changes in health behavior and health among DM2 and CAD patients.

    Scandinavian journal of medicine & science in sports·2016
    Same journal

    Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

    The American journal of medicine·2026
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric panniculitis.

    The American journal of medicine·2026
    See all related articles

    This study details a successful treatment for a boy with chronic obstructive liver disease and hyperlipidemia. Medical interventions, including cholestyramine and phenobarbital, normalized lipid and bile acid levels by enhancing enterohepatic circulation.

    Area of Science:

    • Hepatology
    • Immunology
    • Metabolic Disorders

    Background:

    • Chronic obstructive liver disease (COLD) can lead to secondary hyperlipidemia.
    • Immunodeficiency presents unique challenges in managing complex metabolic conditions.

    Observation:

    • A patient with immunodeficiency developed COLD and hyperlipidemia.
    • Initial bile drainage showed some response.
    • Xanthomas and pruritus were significant clinical manifestations.

    Findings:

    • Sequential administration of cholestyramine and phenobarbital led to symptom resolution.
    • Serum lipid and bile acid concentrations were restored to normal ranges.
    • Treatment effectively shifted the bile acid pool from peripheral circulation to the enterohepatic circulation.

    Related Experiment Videos

    Implications:

    • This therapeutic approach offers a potential strategy for managing similar cases.
    • Understanding bile acid pool dynamics is crucial in treating liver and lipid disorders.
    • Further research into immunodeficiency-related metabolic complications is warranted.